Adastra's license also permits it to produce and offer psilocybin and psilocin -- hallucinogens more frequently often known as magic mushrooms that deliver results comparable to LSD. The licensing deal comes following a radical plan change to address an opioid overdose crisis which has killed countless numbers, by decriminalizing compact amounts